We also found that this triple drug combination significantly decreased the expression of CXCR4, another signal known to govern the metastatic phenotype of CRC cells, partially via AKT-ERK1/2 pathway [32, 33] (Figure 2B). Here, CXCR4 is linked to colorectal carcinoma.